What is the financial benefit for Magnus Ohman as an official reviewer for the AHA?
E. Magnus Ohman is an official reviewer for the AHA and his financial benefit includes Abiomed, Datascope, Inovise*, Liposcience, The Medicines Company, Response Biomedical, CV Therapeutics*, The Medicines Company*, Inovise*, Bristol-Myers Squibb*, Daiichi-Sankyo*, Eli Lilly*, The Medicines Company*, Millennium Pharmaceuticals*, Sanofi-aventis*, and Schering-Plough*.